BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30787679)

  • 1. Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Bone Transplantation on the Treatment Outcome of Non-Malignant Disease.
    Choi YB; Lee JW; Sung KW; Koo HH; Kim HJ; Yoo KH
    J Korean Med Sci; 2019 Feb; 34(6):e46. PubMed ID: 30787679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor-Host Lineage-Specific Chimerism Monitoring and Analysis in Pediatric Patients Following Allogeneic Stem Cell Transplantation: Influence of Pretransplantation Variables and Correlation with Post-Transplantation Outcomes.
    Llaurador G; Nicoletti E; Prockop SE; Hsu S; Fuller K; Mauguen A; O'Reilly RJ; Boelens JJ; Boulad F
    Transplant Cell Ther; 2021 Sep; 27(9):780.e1-780.e14. PubMed ID: 34082161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimerism in pediatric hematopoietic stem cell transplantation and its correlation with the clinical outcome.
    Gabr H; Youssry I; El-Ansary Y; Mosallam G; Riad NM; Hanna MOF
    Transpl Immunol; 2017 Dec; 45():53-58. PubMed ID: 28951259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of early chimerism status on clinical outcome in children with acute lymphoblastic leukaemia after haematopoietic stem cell transplantation.
    Lejman M; Zaucha-Prażmo A; Zawitkowska J; Mroczkowska A; Grabowski D; Kowalczyk JR; Drabko K
    BMC Cancer; 2019 Nov; 19(1):1141. PubMed ID: 31771553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood late mixed chimerism in leucocyte subpopulations following allogeneic stem cell transplantation for childhood malignancies: does it matter?
    Pichler H; Fritsch G; König M; Daxberger H; Glogova E; Pötschger U; Breuer S; Lawitschka A; Güclü ED; Karlhuber S; Holter W; Haas OA; Lion T; Matthes-Martin S
    Br J Haematol; 2016 Jun; 173(6):905-17. PubMed ID: 26996395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of chimerism in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation].
    Furukawa T; Hashimoto S; Inano K; Yamazaki F; Takeda H; Kakihara T; Yano T; Abe T; Higuchi W; Toba K; Takahashi M; Koike T; Aizawa Y
    Rinsho Ketsueki; 2001 Jun; 42(6):488-95. PubMed ID: 11505528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of hematopoietic chimerism after non-myeloablative allogeneic peripheral blood stem cell transplantation].
    Chen BA; Xiong HX; Ding JH; Su EB; Zhao G; Wang J; Gao C; Sun YY; Cheng J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):313-7. PubMed ID: 16638205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparative study of unrelated donor and matched-sibling donor allogeneic hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia].
    Zhou J; Fu YW; Liang LJ; Wang Q; Han LJ; Zu YL; Zhang Y; Zhu XH; Yu FK; Fang BJ; Wei XD; Song YP
    Zhonghua Nei Ke Za Zhi; 2016 Dec; 55(12):927-931. PubMed ID: 27916046
    [No Abstract]   [Full Text] [Related]  

  • 9. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
    Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of serial quantitative analysis of hematopoietic chimerism after allogeneic stem cell transplantation in children for severe aplastic anemia.
    Hoelle W; Beck JF; Dueckers G; Kreyenberg H; Lang P; Gruhn B; Führer M; Niethammer D; Klingebiel T; Bader P
    Bone Marrow Transplant; 2004 Jan; 33(2):219-23. PubMed ID: 14647253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic hematopoietic SCT in patients with non-malignant diseases, and importance of chimerism.
    Svenberg P; Mattsson J; Ringdén O; Uzunel M
    Bone Marrow Transplant; 2009 Dec; 44(11):757-63. PubMed ID: 19421178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed chimerism after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia.
    Zhang Y; Li Y; Wu L; Zhou M; Wang C; Mo W; Chen X; Xu S; Zhou R; Wang S; Zhang Y
    Hematology; 2021 Dec; 26(1):435-443. PubMed ID: 34130602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic significance of early phase donor chimerism after allogeneic peripheral blood stem cell transplantation].
    Zhai WH; Liu QZ; Shi YY; Li G; Sun JL; Chen X; Yao JF; Su XH; Ma QL; Pang AM; He Y; Yang DL; Zhang RL; Huang Y; Wei JL; Feng SZ; Han MZ; Jiang EL
    Zhonghua Xue Ye Xue Za Zhi; 2018 Nov; 39(11):932-936. PubMed ID: 30486591
    [No Abstract]   [Full Text] [Related]  

  • 14. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation].
    Tang XW; Wu DP; Zhu ZL; Wang W; Sun AN; Qiu HY; Fu ZZ; Chang WR; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed T Cell Chimerism After Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using an Alemtuzumab-Containing Regimen Is Shaped by Persistence of Recipient CD8 T Cells.
    Grimaldi F; Potter V; Perez-Abellan P; Veluchamy JP; Atif M; Grain R; Sen M; Best S; Lea N; Rice C; Pagliuca A; Mufti GJ; Marsh JCW; Barber LD
    Biol Blood Marrow Transplant; 2017 Feb; 23(2):293-299. PubMed ID: 27816648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of chimerism after allogeneic hematopoietic stem cell transplantation in children with non-malignant diseases.
    Park M; Koh KN; Seo JJ; Im HJ
    Korean J Hematol; 2011 Dec; 46(4):258-64. PubMed ID: 22259632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children.
    Bader P; Hölle W; Klingebiel T; Handgretinger R; Benda N; Schlegel PG; Niethammer D; Beck J
    Bone Marrow Transplant; 1997 Apr; 19(7):697-702. PubMed ID: 9156247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed Chimerism and Secondary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia.
    Kako S; Yamazaki H; Ohashi K; Ozawa Y; Ota S; Kanda Y; Maeda T; Kato J; Ishiyama K; Matsuoka KI; Miyamoto T; Iida H; Ikegame K; Fukuda T; Ichinohe T; Atsuta Y; Mori T;
    Biol Blood Marrow Transplant; 2020 Mar; 26(3):445-450. PubMed ID: 31618688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrow transplantation: a prospective study.
    Choi SJ; Lee KH; Lee JH; Kim S; Chung HJ; Lee JS; Kim SH; Park CJ; Chi HS; Kim WK
    Bone Marrow Transplant; 2000 Aug; 26(3):327-32. PubMed ID: 10967574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of formation and conversion of hematopoietic mixed chimerism in nonmyeloablative allogeneic stem cell transplantation].
    Ai HS; Yu CL; Wang DH; Guo M; Qiao JH; Shi BF; Sun WJ; Zhang S; Sun QY; Yao B
    Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(3):208-11. PubMed ID: 12812663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.